COMMISSION IMPLEMENTING REGULATION (EU) 2024/2576
of 2 October 2024
approving 2-methyl-4-oxo-3-(prop-2- ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate (prallethrin) as an existing active substance for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council
(Text with EEA relevance)
Article 1
Article 2
ANNEX
Common Name |
IUPAC Name Identification Numbers |
Minimum degree of purity of the active substance(1) |
Date of approval |
Expiry date of approval |
Product type |
Specific conditions |
||||||||||||||
prallethrin |
IUPAC name: 2-methyl-4-oxo-3-(prop-2-ynyl)cyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate EC No: 245-387-9 CAS No: 23031-36-9 |
92,0 % weight per weight (w/w) Note: 1R-trans, S isomer are present at > 80 % (w/w) |
1 March 2026 |
29 February 2036 |
18 |
Prallethrin is considered a candidate for substitution in accordance with Article 10(1), point (d), of Regulation (EU) No 528/2012. The authorisation of biocidal products containing prallethrin as an active substance is subject to the following conditions:
The placing on the market of treated articles is subject to the following conditions:
|